NewsRoom Articles - Page 253 of 611

ThursdayAug 26, 2021 4:20 am

420 with CNW — Why Similar CBD Products Often Have Different Prices

The difference in the prices of CBD products around the world has become more obvious in the past year. Since the coronavirus pandemic began, the demand for these products has risen significantly, and so has the production of cheap and expensive CBD products. Currently, the price difference between the least and most expensive products is about 4,715%. The gap is too large to be overlooked, given most CBD products are often used for various medical conditions, which is why these products should be evenly priced, thereby allowing everyone to have access to them. What is causing this huge difference in…

WednesdayAug 25, 2021 4:20 pm

420 with CNW — Gallup Poll: Nearly 50% of Adult Americans Have Used Marijuana

Cannabis is more popular among Americans than it has ever been. After decades of prohibition, the past few years have seen dozens of states pass cannabis legislation, and thanks to constant demand, the nascent state-legal cannabis industry has already generated billions of dollars in revenue. The controversial plant has been the most-used drug in the United States for years and according to a recently released poll by Gallup, nearly half of the adults in the country have consumed cannabis at one point in their lives. An estimated 49% of American adults have used cannabis at some point in their lives,…

WednesdayAug 25, 2021 11:12 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Pursues Commercial Production of Rare Cannabinoids at Pharmaceutical Levels

Canadian clinical-stage drug development company InMed Pharmaceuticals is working to achieve pharmaceutical approval of rare cannabinoids InMed Pharmaceutical has developed a trademarked platform called IntegraSyn that extracts five times the normally expected yields of cannabinoids from its plant sources IntegraSyn’s ability to increase yields may ultimately help InMed to achieve a profitable means of producing cannabinol (“CBN”) and other lesser-known cannabinoids at commercial scales To date, GW Pharma’s Epidiolex is the only cannabis-derived product to achieve FDA approval as a pharmaceutical, and the company’s multi-million-dollar revenues demonstrate the potential returns a pharmaceutical-level drug can achieve British Columbia, Canada-based InMed Pharmaceuticals…

WednesdayAug 25, 2021 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Completes Acquisition of Apopka Cultivation Facility Further Expanding Florida Footprint

Red White & Bloom Inc. recently completed the acquisition of an operational 45,000 square-foot greenhouse situated on 4.7 acres of land in Apopka, Florida The acquisition comes less than four months after the company closed the purchase of a property in Sanderson, Florida RWB is intent on expanding its cultivation footprint in Florida as it also seeks to grow the number of retail stores in the state The Apopka facility will add near term cultivation capacity as RWB waits for the Sanderson facility to become operational A little less than four months after completing the acquisition of a property in…

WednesdayAug 25, 2021 4:20 am

420 with CNW — Four States Notch Record-Setting July Cannabis Sales

Last month was an extremely profitable and productive month for the cannabis industry in different states across the country, with business owners reporting record-breaking sales. This trend has been observed in various states as the marijuana markets mature, which is impressive, especially when one considers how the marijuana industry has flourished despite the COVID-19 pandemic. Below are some of the few states that posted new sales records in the month of July. Missouri Medical marijuana sales in the state of Missouri surpassed $20 million last month, with analysts noting that this amount was mainly attributed to growing patient enrollment in…

TuesdayAug 24, 2021 4:20 pm

420 with CNW — As Cannabis Legalization Spreads, Companies Are Reconsidering Drug Policies

America's increasingly liberal attitude regarding cannabis consumption has started to impact workplace policies. For decades, both federal and state law outlawed cannabis, which was in turn mirrored in workplace policies across the country. Most employers had a zero-tolerance policy on cannabis, with some even requiring regular drug tests and firing employees who failed. But with cannabis reform sweeping the nation, companies are starting to reconsider their drug policies. This became increasingly clear when Amazon, the largest player in the e-commerce market with 1.3 million employees around the world, announced that it would cease testing job seekers for marijuana. A lot…

TuesdayAug 24, 2021 10:42 am

Podcast Notes Blood Pressure Drug Delivery Trial Successes of Innovative Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology

Lexaria Bioscience is a drug delivery technology innovator whose flagship technology, DehydraTECH(TM), provides a means of enhancing substances’ delivery time to increase their effectiveness without adverse effects A new podcast by NetworkNewsAudio highlights DehydraTECH’s successes in trials that measure blood pressure reduction using DehydraTECH-enhanced CBD in comparison with generic controls The DehydraTECH technology is also being analyzed for effectiveness in combatting inflammatory conditions, viral illnesses and alternatives to the lung-harming effects of smoking The company’s most recent filing with the SEC notes that its revenues more than doubled between May 2020 and May 2021, driven largely by product sales and…

TuesdayAug 24, 2021 4:20 am

420 with CNW — Nevada Judge Overturns Las Vegas PD Marijuana Ban

Employees may have finally seen a reprieve in the battle between federal and state cannabis law after a Nevada judge overturned a Las Vegas Police Department ban on marijuana consumption among its staff. Although more than two dozen states have passed either medical or recreational cannabis legislation, federal law still classifies it as a Schedule I drug. That may change in the near future. Meanwhile, employees living in legal cannabis markets often find themselves penalized by their bosses for consuming cannabis during personal hours. According to a ruling by a Las Vegas district judge, a former LVPD officer should not…

MondayAug 23, 2021 4:20 pm

420 with CNW — A Comparison Between Cannabis Edibles and Infused Drinks

Over the last decade, marijuana-infused drinks have improved greatly in both consistency and flavor. As more states across the country legalize marijuana for recreational and/or medicinal use, the use of cannabis products such as marijuana edibles and marijuana-infused drinks grows. The search for alternatives to alcohol and alcoholic beverages has also boosted the consumption of these drinks. An report by BDS Analytics has found that roughly 20% of marijuana consumers are now consuming marijuana beverages in legal markets for various reasons, whether it’s to have fun, feel peaceful or relax. So, how are these beverages made? CBD and THC are…

MondayAug 23, 2021 12:04 pm

Golden Triangle Ventures Inc. (GTVH) Sees Promise in VR Concerts, Events; Partners with Leading VR Technology Company

Forbes article reports that the “business of music” becomes challenging for artists when they are unable to perform VR concerts are potentially much more lucrative than online pay-per-view concerts GTVH’s five-year agreement with Positron places the company in a strong position in the VR event space The business of making music — and a living — became very complicated for artists during COVID-19. Most musicians make the bulk of their living through live performances and appearances, an impossibility during the global pandemic. Online pay-per-view performances became an option, but Golden Triangle Ventures (OTC: GTVH) believes the real promise is in virtual reality…